S100B and depressive disorder: Although elevated levels of S100B in MDD patients (Schroeter et al., 2013; Shi et al., 2020) and positive correlations between S100B levels and depression severity (Schroeter et al., 2013) have been reported, also reduced levels have been found in cerebrospinal fluid of depressed subjects (Uher and Bob, 2012).